C09D 105/10
Heparin
Official title: Heparin; Derivatives thereof
C09D105/10 (Heparin) appears on 12 US grants and 18 published applications in this corpus.
Search patents in C09D- Granted patents
- 12
- Published applications
- 18
- Assignees
- 11
- Inventors
- 32
- Latest grant
- 29 May 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 2 |
| 2003 | 2 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 2 |
| 2007 | 0 | 1 |
| 2008 | 1 | 2 |
| 2009 | 2 | 4 |
| 2010 | 0 | 0 |
| 2011 | 1 | 2 |
| 2012 | 2 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 2 | 2 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
By publication year.
Recent patents
- Anti-thrombogenic grafts29 May 2018US 9,981,066 B2Yale University
- Heparin prodrugs and drug delivery stents formed therefrom28 Jun 2016US 9,375,445 B2Abbott Cardiovascular Systems Inc.
- Heparin prodrugs and drug delivery stents formed therefrom14 Jun 2016US 9,364,498 B2Abbott Cardiovascular Systems Inc.
- Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same11 Dec 2012US 8,329,157 B2Advanced Cardiovascular Systems, Inc.
- Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same11 Dec 2012US 8,329,158 B2Advanced Cardiovascular Systems, Inc.
- Method for immobilizing heparin and no-generating catalyst and cardiovascular device having surface modified using the same27 May 2021US 2021/0154373 A1Ajou University Industry-Academic Cooperation Foundation
- Anti-thrombogenic grafts30 Aug 2018US 2018/0243482 A1Yale University
- Cosmetic Formulation Incorporating a UV-Triggered Self-Healing Material18 Aug 2016US 2016/0235650 A1Avon Products, Inc.
- Anti-thrombogenic grafts3 Mar 2016US 2016/0058913 A1Yale University
- Antithrombic coatings and uses thereof18 Sep 2014US 2014/0272232 A1
Most cited
By later US patents
- Amphipathic coating for modulating cellular adhesion composition and methods73US 6,342,591 B12002
- Nucleic acid coating compositions and methods33US 6,596,699 B2BioSurface Engineering Technologies, Inc. · 2003
- Silyl and Heparin compositions21US 6,630,580 B2Innerdyne, Inc. · 2003
- Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same18US 8,329,158 B2Advanced Cardiovascular Systems, Inc. · 2012
- Heparin prodrugs and drug delivery stents formed therefrom18US 9,375,445 B2Abbott Cardiovascular Systems Inc. · 2016